Stories

Nancy Ngum and Paul Tanui (AUDA-NEPAD), Ms. Mimi Darko (Ghana FDA), and Kate Kikule (MTaPS)

Regional regulatory leaders, representatives from academia, and development organizations gathered in Accra, Ghana, in June to review a new monitoring and evaluation (M&E) tool that promises to improve access to safe, affordable medicines in several African countries by measuring the performance of Regional Centres of Regulatory Excellence (RCOREs).The African Union Development Agency (AUDA-NEPAD), in collaboration with the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program, supported the validation of the M&E tool.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

MSH’s President and CEO, Marian W. Wentworth, will join the World Health Organization (WHO)’s Malaria Vaccine Advisory Committee (MALVAC) for a two-year appointment.

Left to right: Dr. Daniel Gemechu, Regional Director for CTB/Ethiopia , Dr. Ahmed Bedru, Country Director for CTB/Ethiopia , Mr. Taye Letta, National TB Program Manager, Dr. Liya Tadesse, State Minister of Health, Dr. Kitty van Weezenbeek, Executive Director of KNCV and Dr. Pedro Suarez, Senior Director, Infectious Disease Cluster at MSH.

At last week’s end of project ceremony, the USAID-funded Challenge TB project celebrated improvements in Ethiopia’s ability to save lives by detecting, diagnosing, and treating TB more effectively.Under this five-year program, USAID invested $42 million to improve the quality of TB care and prevention services, enabling patients to receive better access to treatment and medication to fight the disease. TB deaths have dropped significantly as treatment success rates rose above 90%, with 75% of those suffering from multidrug-resistant TB now able to beat the disease after comple

Pages